Pharma commercial analytics · EVERSANA
EVERSANA
End-to-end pharma commercialization partner covering market access, patient services, field deployment, and RWE.
EVERSANA is a commercialization partner for pharmaceutical and biotech companies, providing outsourced or co-sourced services across pricing and market access, patient services and specialty pharmacy, field sales deployment, digital and channel marketing, reimbursement support, and real-world evidence generation. Rather than selling a single analytics product, it functions as an extended commercial organization that a sponsor can plug into at launch or throughout a product's lifecycle, combining consulting, technology, and operational execution such as running field teams or a hub services program. This distinguishes it from analytics-only vendors like ZS or platform vendors like Aktana: EVERSANA often executes the commercial function itself, using its own data and technology layer to support decisions. It serves companies ranging from pre-launch biotechs without commercial infrastructure to established manufacturers of specialty and complex therapies, and expanded further in 2025 through a merger with Waltz Health covering drug-price marketplaces.
At a glance
| Vendor | EVERSANA |
|---|---|
| Pricing model | Quote only |
| Free tier | No |
| Deployment | Cloud |
| Open source | No |
| Best for | Pre-launch and emerging biotechs needing an outsourced commercial organization rather than just analytics software. |
Pricing
Services and technology are quoted per engagement directly by EVERSANA; no public price list.
Pricing has not been verified yet — see the vendor's site.
Features
- Pricing and market access strategy
- Patient services and specialty pharmacy support
- Outsourced field sales deployment
- Digital and channel marketing execution
- Reimbursement and hub services support
- Real-world evidence generation
- Launch planning and commercialization strategy
Profile last reviewed September 21, 2026